Kalogon, Inc. — SEC Form D Filing
Kalogon, Inc. filed an SEC Form D on June 23, 2026, reporting $5.75M raised in Medical Devices.
Form D filing details
- Filing
- SEC Form D
- Filing date
- June 23, 2026
- Amount reported
- $5.75M
- Industry
- Medical Devices
- Website
- https://www.kalogon.com/
What the company does
Securities: Equity. Exemption: Rule 506(b). Incorporated: DELAWARE
Problem
People who must sit for extended periods experience stresses and health issues. Kalogon aims to eliminate these stresses and improve overall health for constant sitters.
Solution
Kalogon develops advanced, novel seating solutions and smart seating technologies designed to enhance comfort, protect health, and improve outcomes for individuals who need to sit for long durations.
Verdict
Investors backed this medical device play because of the clear and immediate need for pressure injury prevention in an aging population with chronic conditions, not because of a disruptive technological leap in materials science. The implicit bet was on market adoption driven by healthcare cost savings and improved patient outcomes. Upside was limited by the specialized niche and the established, albeit less technologically advanced, competitive landscape, which confined the addressable market to clinical settings rather than broader consumer adoption.
Source: SEC EDGAR Form D filing